Skip to main content
. Author manuscript; available in PMC: 2024 Oct 13.
Published in final edited form as: Vaccine. 2023 Sep 14;41(43):6461–6469. doi: 10.1016/j.vaccine.2023.08.071

Figure 7. Proportion of infections averted due to a 1.0 log10 vaccine at varying coverage levels.

Figure 7.

The mean proportion of cumulative infections averted by the vaccine relative to the no-vaccine scenario at varying coverage levels of a vaccine that reduced phenotypic SPVL by 1.0 log10 copies/ml. Bars represent 95% confidence intervals.